menu
    • menu

    Company profile for MGB Biopharma

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MGB Biopharma’s focus is to further develop their completely new class of anti-infective medicine, starting with antibiotics based on Minor Groove Binder (MGBs) compounds. The Company’s experienced management team have dedicated their initial focus to the development of a new class of small molecules, with specific antibacterial activity against susceptible and resistant bacteria. In providing a new class of drug to the fi...
    MGB Biopharma’s focus is to further develop their completely new class of anti-infective medicine, starting with antibiotics based on Minor Groove Binder (MGBs) compounds. The Company’s experienced management team have dedicated their initial focus to the development of a new class of small molecules, with specific antibacterial activity against susceptible and resistant bacteria. In providing a new class of drug to the field of antibacterial resistance, based on a truly novel mechanism of action, MGB Biopharma are unique, in that a truly new class and novel MoA was last seen in the year 2000.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MGB Biopharmaunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Suite 1-2, Willow House, Strathclyde Business Park, Kestrel View, Bellshill ML...
    Telephone
    Telephone
    +44 (0)169 846 4224
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mgb-biopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mgb-biopharma-ltd
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/MGB_Biopharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MGB Biopharma - Successful End-of-Phase 2 Meeting with FDA for MGB-BP-3
    MGB Biopharma - Successful End-of-Phase 2 Meeting with FDA for MGB-BP-3

    26 Jan 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/mgb-biopharma---successful-end-of-phase-2-meeting-with-fda-for-mgb-bp-3-a-potential-new-gold-standard-first-line-treatment-for-clostridioides-difficile-infection-cdi-301215669.html

    PRNEWSWIRE
    26 Jan 2021
    Share Share
    MGB Biopharma Announces Successful Outcome From Ph II Study with MGB-BP-3
    MGB Biopharma Announces Successful Outcome From Ph II Study with MGB-BP-3

    19 May 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mgb-biopharma-announces-successful-outcome-from-phase-ii-clinical-study-with-mgb-bp-3--a-potential-new-gold-standard-first-line-treatment-for-clostridium-difficile-infection-cdi-301061497.html

    PR NEWSWIRE
    19 May 2020
    Share Share
    MGB Biopharma Announces Successful Outcome From PhII Study with MGB-BP-3
    MGB Biopharma Announces Successful Outcome From PhII Study with MGB-BP-3

    18 May 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/mgb-biopharma-announces-successful-outcome-from-phase-ii-clinical-study-with-mgb-bp-3--a-potential-new-gold-standard-first-line-treatment-for-clostridium-difficile-infection-cdi-301061497.html

    PRNEWSWIRE
    18 May 2020
    Share Share
    MGB Biopharma reveals positive mid-stage diarrhoea data
    MGB Biopharma reveals positive mid-stage diarrhoea data

    11 Oct 2019

    // Anna Smith PHARMATIMES

    http://www.pharmatimes.com/news/mgb_biopharma_reveals_positive_mid-stage_diarrhoea_data_1312794

    Anna Smith PHARMATIMES
    11 Oct 2019
    Share Share
    MGB tops up cash pool to wrap up antibiotic phase 2a
    MGB tops up cash pool to wrap up antibiotic phase 2a

    30 Aug 2019

    // Nick Paul FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/mgb-tops-up-cash-pool-to-wrap-up-antibiotic-phase-2a

    Nick Paul FIERCE BIOTECH
    30 Aug 2019
    Share Share
    Catalent Accelerates Formulation and Supply for MGB Biopharma Candidate
    Catalent Accelerates Formulation and Supply for MGB Biopharma Candidate

    26 Apr 2019

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2019-04-26/catalent-accelerates-formulation-and-supply-for-mgb-biopharma-candidate/

    CONTRACTPHARMA
    26 Apr 2019
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search